Clinical and Laboratory Factors Associated with Symptom Development in Asymptomatic COVID-19 Patients at the Time of Diagnosis

被引:2
|
作者
Oh, Hong Sang [1 ]
Kim, Joon Ho [2 ]
Woo, Myoung Lyeol [3 ]
Kim, Ji-Yeon [4 ]
Park, Chul Hee [5 ]
Won, Hyejin [6 ]
Lim, Seungkwan [7 ]
Jeong, Hyeonju [7 ,8 ]
Ham, Sin Young [8 ,13 ]
Kim, Eun Jin [9 ]
Sheen, Seungsoo [10 ]
Kang, Yu Min [11 ]
Yoon, Doran [1 ]
Lee, Seung Youp [12 ]
Song, Kyoung-Ho [8 ]
机构
[1] Armed Forces Capital Hosp, Dept Internal Med, Seongnam, South Korea
[2] Uijeongbu Hosp, Gyeonggi Prov Med Ctr, Dept Surg, Uijongbu, South Korea
[3] Uijeongbu Hosp, Gyeonggi Prov Med Ctr, Dept Internal Med, Uijongbu, South Korea
[4] Seongnam Citizens Med Ctr, Dept Med, Div Infect Dis, Seongnam, South Korea
[5] Icheon Hosp, Gyeonggi Prov Med Ctr, Dept Internal Med, Icheon, South Korea
[6] Pocheon Hosp, Gyeonggi Prov Med Ctr, Dept Internal Med, Pochon, South Korea
[7] Ansung Hosp, Gyeonggi Prov Med Ctr, Dept Internal Med, Anseong, South Korea
[8] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Internal Med, 82,Gumi Ro 173 Boom Gil, Seongnam 13620, South Korea
[9] Ajou Univ, Sch Med, Dept Infect Dis, Suwon, South Korea
[10] Ajou Univ, Sch Med, Dept Pulm Crit Care Med, Suwon, South Korea
[11] Myongji Hosp, Dept Internal Med, Div Infect Dis, Goyang, South Korea
[12] Ansung Hosp, Gyeonggi Prov Med Ctr, Dept Emergency Med, 95 Nampa Ro, Anseong 11671, South Korea
[13] Vet Hlth Serv Med Ctr, Dept Internal Med, Seoul, South Korea
关键词
COVID-19; SARS-CoV-2; Asymptomatic; Symptom development; Medical resource allocation; CORONAVIRUS DISEASE;
D O I
10.3947/ic.2021.0077
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In preparation for the surge of coronavirus disease 2019 (COVID-19), it is crucial to allocate medical resources efficiently for distinguishing people who remain asymptomatic until the end of the disease. Between January 27, 2020, and April 21, 2020, 517 COVID-19 cases from 13 healthcare facilities in Gyeonggi province, Korea, were identified out of which the epidemiologic and clinical information of 66 asymptomatic patients at the time of diagnosis were analyzed retrospectively. An exposure-diagnosis interval within 7 days and abnormal aspartate aminotransferase levels were identified as characteristic symptom development in asymptomatic COVID-19 patients. If asymptomatic patients without these characteristics at the time of diagnosis could be differentiated early, more medical resources could be secured for mild or moderate cases in this COVID-19 surge.
引用
收藏
页码:786 / 791
页数:6
相关论文
共 50 条
  • [31] Clinical Laboratory Markers in COVID-19
    Iqbal, Mohammad Zahidul
    Zohra, Benazeer
    ANNALS OF KING EDWARD MEDICAL UNIVERSITY LAHORE PAKISTAN, 2021, 27 (04): : 576 - 585
  • [32] Risk factors associated with hospitalization in patients with asymptomatic or mild COVID-19 in public accommodation facilities in Tokyo
    Sakamoto, Yohei
    Satoh, Kenichi
    Tanaka, Takuma
    Yamaguchi, Takayuki
    Miyamoto, Tomomi
    Sawaki, Kenji
    Miyajima, Makiko
    Nakaharai, Kazuhiko
    Hoshina, Tokio
    Horino, Tetsuya
    Nakazawa, Yasushi
    Ikenoue, Tatsuyoshi
    Yoshida, Masaki
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (10) : 1439 - 1444
  • [33] Diagnosis of COVID-19 pneumonia in asymptomatic patients after an oncological PET/CT
    Mucientes Rasilla, J.
    Jimeno Pernett, R.
    Cardona Arbonies, J.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2020, 39 (05): : 299 - 302
  • [34] Analysis of Mortality in Patients With COVID-19: Clinical and Laboratory Parameters
    Tian, Sufang
    Liu, Huan
    Liao, Meiyan
    Wu, Yingjie
    Yang, Chunxiu
    Cai, Yuxiang
    Peng, Zhiyong
    Xiao, Shu-Yuan
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (05):
  • [35] Clinical heterogeneity in patients with myoclonus associated to COVID-19
    Gary Álvarez Bravo
    Laura Sánchez Cirera
    Mònica Angerri Nadal
    Lluís Ramió i Torrentà
    Neurological Sciences, 2022, 43 : 1587 - 1592
  • [36] RISK FACTORS FOR THE DEVELOPMENT OF SARCOPENIA IN PATIENTS WITH COVID-19
    Gonzalez Islas, Dulce
    Miguel Sanchez-Moreno, Carlos
    Orea-Tejeda, Arturo
    Fernanda Salgado-Fernandez, Maria
    Samantha Hernandez-Lopez, Andrea
    Galicia-Amor, Susana
    Trejo-Mellado, Esperanza
    Garcia-Hernandez, Juan
    Orozco-Gutierrez, Juan
    Aboitiz-Rivera, Carlos
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [37] A Symptom-Based Rule for Diagnosis of COVID-19
    David S. Smith
    Elizabeth A. Richey
    Wendy L. Brunetto
    SN Comprehensive Clinical Medicine, 2020, 2 (11) : 1947 - 1954
  • [38] A systematic review of clinical and laboratory parameters associated with increased severity among COVID-19 patients
    Mehta, Asmita A.
    Haridas, Nithya
    Belgundi, Preeti
    Jose, Wesley M.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (02) : 535 - 541
  • [39] Clinical heterogeneity in patients with myoclonus associated to COVID-19
    Alvarez Bravo, Gary
    Sanchez Cirera, Laura
    Angerri Nadal, Monica
    Torrenta, Lluis Ramio, I
    NEUROLOGICAL SCIENCES, 2022, 43 (03) : 1587 - 1592
  • [40] Clinical outcome and associated factors in patients with COVID-19 admitted to an Intensive Care Unit
    Albuquerque Silva, Paola Frassinette de Oliveira
    Do Nascimento, Claudete Xavier
    Guedes Lima Da Silva, Jessica Cristina
    Lima Chagas, Camila
    Silva Pereira, Danielle Erilane
    Bezerra Da Silva, Maria da Guia
    Oliveira Tomiya, Marilia Tokiko
    NUTRICION CLINICA Y DIETETICA HOSPITALARIA, 2022, 42 (04): : 99 - 107